| Kallam Anji Reddy | |
|---|---|
| Born | 1940 Tadepalli, Guntur district |
| Nationality | Indian |
| Occupation | Chairman, Dr Reddy's Labs |
Kallam Anji Reddy (born 1940) is an Indian entrepreneur in the pharmaceutical industry, the founder-chairman of Dr Reddy's Labs, which he established in 1984, and chairman of Dr Reddy’s Foundation (DRF), the corporate social responsibility arm of the group, established 1996.[1][2] The Government of India, has honoured him with Padmabhushan for his contribution to the Indian Pharmaceutical industry. He is a member of the Indian Prime Minister's Council on Trade and Industry.[3]
|
Contents
|
He spent his early years in the village of near suryapet nalgonda in nalgonda District, where his father grew turmeric. He studied in Anapothana ZPHS School in Nutakki until Tenth Class.
Reddy after graduating from the local high school, went on to get his first Bachelor of science degree from A.C. College at Guntur in 1958.[4] Thereafter he, did his B.Sc.-Tech in Pharmaceuticals and Fine chemicals from Bombay University followed by a Ph.D. in chemical engineering from the National Chemical Laboratory, Pune in 1969.[5]
He started his career in the state-owned PSU, Indian Drugs and Pharmaceuticals Limited (IDPL) (1969–1975), when he left the job to found Uniloids Ltd in 1976 of which was also the and managing director of till 1980, when he founded Standard Organics Limited, before founding Dr Reddy's Labs in 1984 with an initial capital of Rs 25 lakh (Rs 2.5 million). Over the years, it transformed Indian bulk drug industry from import-dependent in mid-80s to self-reliant in mid-90s and finally into the export-oriented industry.[5]
Dr. Reddy's Laboratories has been credited with turning the Indian bulk drug industry from dependence on imports in the mid 1980s to self reliance in the mid 1990s and finally into the export-oriented industry that it is today. It was the first company to take up drug discovery research in India (in 1993). In April 2001 Dr Reddy’s Labs became the first Asian pharmaceutical company outside Japan to be listed on the New York Stock Exchange. The company has revenues of $546 million (Rs.2,427 crore) during the fiscal year 2006 and is India’s second largest pharmaceutical company.
Naandi Foundation, a not-for-profit development institution that strives for eradication of poverty has Dr Reddy as its founding father. He is also founder-chairman of Dr Reddy’s Foundation for Human and Social Development, a social arm of Dr. Reddy’s Labs.
This entry is from Wikipedia, the leading user-contributed encyclopedia. It may not have been reviewed by professional editors (see full disclaimer)